Rejuveron Life Sciences AG — Form D

Rejuveron Life Sciences AG of SCHLIEREN, V8, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-26. The offering totals $16.9M, of which $1.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-03-26
• Form: D
• Accession: 0001849162-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $16.9M
• Amount sold: $1.3M
• Remaining: $15.6M
• Minimum investment: $100K
• Investors: 4
• Date of first sale: 2020-12-09
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-393598

Issuer

• Name: Rejuveron Life Sciences AG
• CIK: 0001849162
• Entity type: Corporation
• Jurisdiction: SWITZERLAND
• Incorporated: 2019
• Address: WAGISTRASSE 18 8952, SCHLIEREN, V8, 00000
• Phone: 0041 78 689 3024

Officers, directors & promoters (2)

More

• CIK 1849162 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search